ConductScience.org, home

Paper16636233

Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage.

Davis SM and 8 others. Neurology, 2006. Cited by 908 papers, by iCite.

Cite this record

ConductScience Library. Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage. Papers, record 16636233. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16636233

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage.
PubMed
Journal
Neurology
PubMed
Year
2006
PubMed
Publication types
Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
908
iCite
Relative citation ratio, by iCite
26.1
iCite
Revised in PubMed
2022-04-08
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Davis SMS M
2Broderick JJ
3Hennerici MM
4Brun NCN C
5Diringer MNM N
6Mayer SAS A
7Begtrup KK
8Steiner TT
9Recombinant Activated Factor VII Intracerebral Hemorrhage Trial InvestigatorsGroup

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cerebral HemorrhageMajor topic
Hematoma, SubduralMajor topic
Aged
Factor VII
Factor VIIa
Female
Humans
Male
Prognosis
Recombinant Proteins
Risk Factors
Tomography, X-Ray Computed

Source PubMed

Download CSV of topics

Trials4

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT00426803Recombinant Factor VIIa in Acute Intracerebral HaemorrhageResultsClinicalTrials.gov
NCT01202864Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH)BackgroundClinicalTrials.gov
NCT01472224Volume Measurement and Progression Surveillance of Intracerebral Haemorrhage Using Transcranial UltrasoundBackgroundClinicalTrials.gov
NCT05118997Active Removal of IntraCerebral Hematoma Via Active IrrigationBackgroundClinicalTrials.gov

Download CSV of trials

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in17283327Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage.https://conductscience.org/library/papers/17283327

Source PubMed

Download CSV of comments and corrections

Cited by447

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 908 citations.

PMIDTitleJournalYearIn PapersSource
42983649A multimodal Vision-Mamba model based on non-contrast CT hematoma and shell features predicts early hematoma expansion in hypertensive intracerebral hemorrhage: a multicenter study.BMC Med Imaging2026https://conductscience.org/library/papers/42983649PubMed
42864513Use of Desmopressin in Spontaneous Nontraumatic Intracerebral Hemorrhage Among Patients Taking Antiplatelet Therapy: Systematic Review and Bayesian Meta-analysis.Neurocrit Care2026https://conductscience.org/library/papers/42864513PubMed
42779188Factors Associated With 90-Day Functional Outcome After Neurosurgical Management of Hypertensive Intracerebral Hemorrhage.Brain Behav2026https://conductscience.org/library/papers/42779188PubMed
42761090Construction of an interpretable prediction model for poor functional outcome in conservatively managed basal ganglia hemorrhage based on CT radiomics and multiple machine learning algorithms.Front Neurol2026https://conductscience.org/library/papers/42761090PubMed
42689324Cilostazol Treatment for Intracerebral Hemorrhage: Targeting Dural Lymphatics.Stroke2026https://conductscience.org/library/papers/42689324PubMed
42652604TeleKap-Supported Intracerebral Haemorrhage Care in Slovenia: Organisational Framework, Potential Benefits, and Evidence Gaps.J Clin Med2026https://conductscience.org/library/papers/42652604PubMed
42601546CT-based prediction of hematoma expansion and adverse outcomes after intracerebral hemorrhage: evidence appraisal, artificial intelligence translation, and GeroScience perspectives.Geroscience2026https://conductscience.org/library/papers/42601546PubMed
42525110The frequency and predictors of hematoma expansion in wake-up intracerebral hemorrhage.Neurol Sci2026https://conductscience.org/library/papers/42525110PubMed
42477258Effect on Mortality of Anticoagulant Reversal in Acute Intracranial Hemorrhage: A Systematic Review and Meta-analysis.Neurocrit Care2026https://conductscience.org/library/papers/42477258PubMed
42396236Current evidence and future directions for prophylactic anticoagulation therapy after severe spontaneous intracerebral hemorrhage: a narrative review.J Intensive Med2026https://conductscience.org/library/papers/42396236PubMed
42355680Is FIB-4 Index an Independent Risk Factor for Hematoma Expansion in Acute Intracerebral Hemorrhage? A Retrospective Multicenter Observational Cohort Study.J Clin Med2026https://conductscience.org/library/papers/42355680PubMed
42318415Research on predicting risk factors for re-bleeding in the acute phase of intracerebral hemorrhage using machine learning algorithms.Front Med (Lausanne)2026https://conductscience.org/library/papers/42318415PubMed
42294608Two Decades of Therapeutic Trials in Supratentorial Intracerebral Haemorrhage: Lessons from Failure and Success.Expert Rev Mol Med2026https://conductscience.org/library/papers/42294608PubMed
42272357Optimising hyperacute intracerebral haemorrhage management: factors influencing timely intervention.Intern Med J2026https://conductscience.org/library/papers/42272357PubMed
42251221Reducing Inequalities in Stroke Events-Hemorrhagic Disparities (RISE-HD): a 10-Year Longitudinal Study in Florida.J Racial Ethn Health Disparities2026https://conductscience.org/library/papers/42251221PubMed
42221216Prognostic Value of the C-Reactive Protein-Albumin-Lymphocyte (CALLY) Index for In-Hospital Mortality in Spontaneous Intracerebral Hemorrhage: A Comparative Analysis with Hematoma Volume.J Inflamm Res2026https://conductscience.org/library/papers/42221216PubMed
42180010Functional outcome prediction across multiple timescales intracerebral hemorrhage using a radiomics model.Eur J Radiol Open2026https://conductscience.org/library/papers/42180010PubMed
42132170Location-Specific Hematoma Volume Tolerance for Spontaneous Intracerebral Hemorrhage: A Pooled Analysis of INTERACT2 and ATACH II.J Am Heart Assoc2026https://conductscience.org/library/papers/42132170PubMed
42131511Immune cells in intracerebral hemorrhage.Brain Hemorrhages2025https://conductscience.org/library/papers/42131511PubMed
42093656Predictors of Hematoma Expansion and Response to Andexanet in Patients With Intracerebral Hemorrhage: Secondary Analyses of the ANNEXA-I Randomized Clinical Trial.Stroke2026https://conductscience.org/library/papers/42093656PubMed

See all 447 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/16636233

GET https://conductscience.org/api/papers/v1/16636233/cited_by?page=2